Traditional approaches to biologics production—relying on one-size-fits-all expression vectors and empirical process optimization—have led to inefficiencies in expression, scalability, and ...

Opportunities include the rising demand for innovative biologics and the increased need for diverse cell lines, including ...

Hyderabad, India, April 14, 2026 (GLOBE NEWSWIRE)-- According to Mordor Intelligence, the global cell line development market is projected to grow from USD 4.97 billion in 2025 to USD 5.48 billion in ...

New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules SEATTLE--(BUSINESS WIRE)-- As drug ...

Mortality disparities among people of different genetic ancestries are increasing, highlighting the need for more diverse ...

Over the past decade, biologics development has moved from artisanal experimentation to a data-driven, platform-based discipline. Analytical depth has improved. Process integration has matured. Yet ...

DURHAM, N.C., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (SCPX) (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization ...

New GMP-grade cell lines with outstanding growth profile outperform industry standards and enable rapid growth performance for cell and gene therapies COLLEGE STATION, Texas--(BUSINESS WIRE)--Matica ...

Discover how to streamline your cell line development process for recombinant protein and monoclonal antibody production with this in-depth eBook. Whether you're working with CHO, HEK293, or hybridoma ...

During a cell line development project, Agenus UK used the Amperia platform in combination with BLI and SPR to analyze antibody titers. The study found a good correlation between the platforms and ...

This webinar explores an integrated approach to mAb development that embeds manufacturability, scalability, lifecycle readiness from the earliest stages.